Open AccessCognitive Decline in Post-treatment Lyme Disease Syndrome
Author(s) -
Pegah Touradji,
John N. Aucott,
Ting Yang,
Alison W Rebman,
Kathleen T. Bechtold
Publication year - 2018
Publication title -
archives of clinical neuropsychology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 98
eISSN - 1873-5843
pISSN - 0887-6177
DOI - 10.1093/arclin/acy051
Subject(s) - cognitive decline , cognition , neurocognitive , neuropsychology , psychology , population , clinical psychology , medicine , psychiatry , disease , dementia , pathology , environmental health
Patient-reported cognitive complaints are common in those with post-treatment Lyme disease syndrome (PTLDS). Objective evidence of cognitive impairment in this population is variable in part due to methodological variability in existing studies. In this study, we sought to use a systematic approach to characterizing PTLDS based on the most current consensus diagnosis. We further examined PTLDS-related cognitive decline, operationalized as a significant decline in cognitive test performance relative to premorbid cognitive ability.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom